Introduction: Severe sepsis and septic shock are advanced clinical conditions representing the patient's response to infection and having a variable but high mortality rate. Early evaluation of sepsis stage and choice of adequate treatment are key factors for survival. Some study results suggest the necessity of daily procalcitonin (PCT) monitoring because of its prognostic and discriminative value. Material and methods: An observational and prospective study was conducted to evaluate the prognostic and discriminative value of PCT kinetics in comparison to PCT absolute value measurements. In a group of 50 intensive care unit patients with diagnosis of severe sepsis or septic shock, serum PCT measurements were performed on admission, and on the 2 nd , 3 rd and 5 th day of therapy. The level of PCT was determined with a commercially available test according to the manufacturer's protocol. Results: The kinetics of PCT assessed by ΔPCT was statistically significant in the survivors vs. the non-survivors subgroup (ΔPCT 3/1 , p = 0.022; ΔPCT 5/1 , p = 0.021). ΔPCT has no statistical significance in the severe sepsis and septic shock subgroups for all analyzed days. Only the 5 th day PCT level was significantly higher in the non-survivors vs. survivors group (p = 0.008). The 1 st day PCT level in the severe sepsis vs. septic shock group has a discriminative impact (p = 0.009). Conclusions: According to the results, single serum PCT measurement, regardless of absolute value, has a discriminative impact but no prognostic significance, during the first 2 days of therapy. The PCT kinetics is of prognostic value from the 3 rd day and is of earlier prognostic significance in comparison to changes in the patient's clinical condition evaluated by SOFA score kinetics.
Introduction
Procalcitonin (PCT) is a prohormone of calcitonin consisting of 114 to 116 amino acids. The physiological PCT serum level is below 0.5 ng/ml, but the rise to a value higher than 2 ng/ml is indicative of sepsis [1] . The PCT induction period at 4 to 12 h is longer than for cytokines, but it is shorter than for C-reactive protein (CRP) [2] . The half-life of PCT is about 22 to 35 h [3] , and in blood samples PCT is a relatively stable protein.
Procalcitonin originates from the calcitonin-I (CALC-I) gene on chromosome 11 [4] . A microbial infection induces a ubiquitous increase in CALC-I gene expression and a significant release of PCT from various tissues and cell types [5] . Tissues with high levels of PCT-I and PCT-II mRNA expression are potential sources of serum PCT in septic conditions [6, 7] . Whang et al. considered that PCT is a secondary mediator, intensifying rather than initiating the septic response [8] . Hoffmann et al. stated that PCT is a modulator of the inflammatory cascade [9] . Furthermore, the extent of PCT release is thought to be closely dependent on the extent of host response to microbial challenge [10] .
Sepsis is not a single disease, but rather a highly heterogeneous syndrome that is the net result of host and pathogen interactions [11] . Severe sepsis/septic shock remains a leading cause of death in the intensive care unit (ICU), with mortality rates varying from 25% to 80% [12] .
The purpose of our study was to assess the predictive and discriminative value of PCT kinetics in comparison to the PCT level in ICU patients with severe sepsis or septic shock during the first 5 days of therapy.
Material and methods

Definition of sepsis, severe sepsis and septic shock
According to the Surviving Sepsis Campaign (SSC) International Guidelines, sepsis is defined as the presence of infection (suspected or documented) in association with systemic manifestation of infection. Severe sepsis is defined as sepsis associated with tissue hypoperfusion or sepsis-induced organ dysfunction (any of the following should result from the infection). Sepsis-induced hypoperfusion is defined as infection-induced hypotension, elevated lactate (> 1 mmol/l), or oliguria. Sepsis-induced hypotension is defined as systolic blood pressure (SBP) < 90 mm Hg or mean arterial pressure (MAP) < 70 mm Hg or SBP decrease > 40 mm Hg or less than two standard deviation below normal for age in the absence of other causes of hypotension. Septic shock is defined as sepsis-induced hypotension persisting despite adequate fluid resuscitation [13] .
Patients
The observational and prospective study was conducted in the Department of Anesthesiology and Intensive Therapy of Wroclaw Medical University, Poland. The research was approved by the Medical Ethics Committee of Wroclaw Medical University and was performed in accordance with Helsinki Declaration of 1975, as revised in 1983. Informed consent was obtained from the patients or their legal representatives.
Fifty critically ill patients were consecutively enrolled in the study starting from admission when they met SSC criteria for severe sepsis or septic shock. On admission to the ICU, patients exhibited different phases of severe sepsis or septic shock. The former antibiotic treatment (ineffective or delayed) and/or the type of experienced surgery influenced the admission PCT concentrations. Patients were divided into the following subgroups: survivors (52%) and non-survivors (48%); severe sepsis (38%) and septic shock (62%). For all patients the following data were reported: age, gender, source of infection, type of causative microorganisms, the Acute Physiology and Chronic Health Evaluation (APACHE) II score [14] on admission, and the Sequential Organ Failure Assessment (SOFA) score [15] and PCT level on admission and on the 2 nd , 3 rd and 5 th day of therapy (Table I ). The treatment of all patients with severe sepsis or septic shock was performed according to established standards, including antimicrobial treatment, fluid resuscitation, vasopressor therapy and mechanical ventilation.
Blood samples were taken in relation to the time of admission to the ICU rather than the onset of sepsis, and were collected on admission (1 st day), and on the 2 nd , 3 rd and 5 th day. The obtained serum was aliquoted and stored at -80°C until further analysis. The PCT level measurements were executed with a commercially available test (LUMItest PCT, BRAHMS Diagnostica GMBH, Germany), according to the manufacturer's instructions. The detection limit of the test was 0.08 ng/ml.
Statistical analysis
All statistical analyses were performed with StatSoft. Inc. (2010) Statistica (data analysis software system), version 9.1. www.statsoft.com. The normality of the distribution was estimated by the Kolmogorov-Smirnov test. The data were analyzed with a nonparametric test (Mann-Whitney U-test) to compare the two groups. APACHE II and SOFA score values are presented as the mean ± SD. P-value ≤ 0.05 was considered statistically significant.
Results
All patients enrolled in the study were classified according to the International Sepsis Definitions Conference guidelines [16] . The patients' status was assessed by APACHE II and SOFA scores. The APACHE II score on the 1 st day in survivors and non-survivors was 18.3 and 27.0, respectively, and in the severe sepsis and septic shock subgroups it was 19.5 and 24.3, respectively. In the non-survivors and septic shock subgroups the most common source of infection was the lung (n = 10 and n = 13, respectively) and abdomen (n = 10 and n = 12, respectively). The mortality rate in the studied critically ill patient group was 48%.
114
Arch Med Sci 1, February / 2016
Kinetics of serum procalcitonin in patient subgroups Table II and for severe sepsis vs. septic shock subgroup in Table III . The PCT level on the 5 th day was significantly higher in the non-survivors than survivors (p = 0.008). In survivors vs. non-survivors subgroups the differences between PCT levels on the 3 rd and 1 st day (ΔPCT 3/1 ), and the differences between PCT levels on the 5 th and 1 st day (ΔPCT5/1) were statistically significant (p = 0.022 and p = 0.021, respectively) (Table II) . In severe sepsis vs. septic shock subgroups the PCT level was statistically significant on the 1 st (p = 0.009) and 3 rd day (p = 0.047), but there was no statistically significant difference in ΔPCT for all analyzed days (Table III) .
Sequential Organ Failure Assessment score changes in patient subgroups
The SOFA score value was significantly different in survivors vs. non-survivors subgroups for all analyzed days, and in contrast to the absolute value, only ΔSOFA 5/1 was significantly different in this subgroup (Table IV) .
In severe sepsis vs. septic shock subgroups the SOFA score value was statistically significant in the course of the study, except for the 5 th day, and there were no statistically significant differences in ΔSOFA in the study (Table V) .
Procalcitonin and receiver operating curve analysis in patient subgroups
In the receiver operating curve (ROC) analysis of the survival on the day of admission the cut-off value for PCT was 16.26 µg/l and area under the curve (AUC) = 0.567, the sensitivity was 0.46, and the specificity was 0.27. On the 2 nd day of therapy the cut-off value was 16.65 µg/l and AUC = 0.567, the sensitiv- ity was 0.42, and the specificity was 0.23. On the 3 rd day of therapy the cut-off value was 5.99 µg/l and AUC = 0.649, the sensitivity was 0.59, and the specificity was 0.24. On the 5 th day of therapy the cut-off value was 0.32 µg/l and AUC = 0.737, the sensitivity was 1.0, and the specificity was 0.567 (Figure 1 A) .
In the ROC curve analysis of the septic shock diagnosis on the day of admission, the cut-off value for PCT was 8.01 µg/l and AUC = 0.72, the sensitivity was 0.70, and the specificity was 0.26. On the 2 nd day of therapy the cut-off value was 5.55 µg/l and AUC = 0.634, the sensitivity was 0.67, and the specificity was 0.37. On the 3 rd day of therapy the cut-off value was 0.6 µg/l and AUC = 0.68, the sensitivity was 0.83, and the spe cificity was 0.47. On the 5 th day of therapy the cut-off value was 1.13 µg/l and AUC = 0.582, the sensitivity was 0.75, and the specificity was 0.46 (Figure 1 B) .
White blood cell and C-reactive protein in patient subgroups
There was no statistically significant difference in the WBC level between the subgroups (Table VI and VII) and the differences in the C-reactive protein (CRP) value were not statistically significant in the course of the study, except for the 5 th day in the survivors vs. non-survivors subgroup (Table VII) .
There was a strong correlation between PCT and WBC on all analyzed days in the survivors subgroup: r 1st day = 0.93, p = 0.00002; r 2nd day = 0.91, p = 0.0001; r 3rd day = 0.92, p = 0.00004; r 5th day = 0.91, p = 0.0001.
In the septic shock subgroup there was a strong correlation between PCT and WBC on all analyzed days except for the 5 th day (r 1st day = 0.79, p = 0.0001; r 2nd day = 0.64, p = 0.003; r 3rd day = 0.55, p = 0.02) and a correlation between PCT and CRP on admission day (r 1st day = 0.53, p = 0.021).
Discussion
Procalcitonin is elevated in patients with severe infections complicated by severe sepsis or septic shock [10] . Monitoring of the PCT concentration is used as an indicator of effectiveness of applied therapy in everyday clinical use. It has been confirmed that the implementation of a PCT-guided algorithm to discontinue antibiotic treatment was associated with a reduced duration of antibiotic therapy in septic ICU patients without negative effects on the final clinical outcome [17] . The usefulness of PCT assessment in sepsis confirmation is well established, but for prediction of survival in septic patients it is still being extensively studied, with conflicting results [18] [19] [20] . In the opinion of some authors the admission PCT level in patients with septic shock is a better prognostic biomarker than CRP, but PCT sensitivity is too low to establish an admission cut-off value for distinguishing survivors from non-survivors [21, 22] . According to Herrmann et al., during the first 5 days of therapy single PCT measurements do not differentiate survivors from non-survivors and significant differences in PCT levels are observed in the second week of the severe sepsis/septic shock course [23] . In our results in the ROC curve analysis for survival the 5 th day of therapy PCT cut-off value represented the best prognostic properties and in the ROC curve analysis for the septic shock diagnosis the 1 st day of therapy PCT cut-off value had the best diagnostic properties.
Currently the discriminative and prognostic significance of PCT level kinetics has started to be an object of clinical research. Karlsson et al. reported that PCT concentrations did not differ between survivors and non-survivors at day 0 and 72 h [24] . In the study by Charles et al. neither 1 st nor 2 nd day PCT level was associated with death in the study population. In Charles' and Sakran's results, like in ours, there was a trend toward higher PCT values in the non-survivors group [25, 26] . In contrast to absolute values, the PCT kinetics (ΔPCT 3/1 , ΔPCT 5/1 ) [27] and Georgopoulou et al. [28] . In Karlsson's study the effect on hospital survival was connected with a decrease in PCT concentrations of greater than 50% between the 1 st and 3 rd study day [24] . ΔPCT 2 nd day -3 rd day was an independent predictor of death in Charles' study group [25] . In Seligman's study the decrease of PCT on the 5 th day vs. 1 st day predicts favorable outcome [29] . In contrast to our results Boussekey et al. stated that PCT decline during the first 2 days of ICU stay was a good indicator of outcome, and PCT increase was an independent risk factor of mortality, with an odds ratio greater than 4 [30] . The PCT level, which was significant only on the 5 th day for survivors vs. non-survivors subgroups, did not reflect statistical significance in SOFA score results observed on all analyzed days. These findings are similar to those of de Oliveira et al. [31] , where not the PCT level but the SOFA score value was highly associated with mortality in ICU patients with severe sepsis and septic shock. In our study in severe sepsis and septic shock subgroups the values of PCT and SOFA score were significantly different on the 1 st day of therapy, similarly to Lavrentieva's study [32] . According to our results in this subgroup the absolute SOFA score value was a better differentiating factor than absolute values of PCT. Kinetics of both elements did not reach statistical significance on any of the study days.
In conclusion, according to our results the PCT absolute values obtained on the 1 st day of therapy significantly differ between severe sepsis and septic shock. Single PCT level measurements during the first 2 days of therapy have no prognostic impact, and the 5 th day of PCT cut-off value represents the best prognostic properties. The PCT kinetics reflecting its level time course is of prognostic value from the 3 rd day of therapy. The significant PCT level decrease reflecting therapy effectiveness might result in a good outcome. The kinetics of PCT achieves prognostic significance earlier than the changes of the patient's clinical condition reflected by kinetics of SOFA score. These results indicate that PCT measurement is needed on an everyday basis because it provides a wide range of patient's evaluation. According to our results the WBC and CRP measurements, though used for everyday septic patient's assessment, have no diagnostic, prognostic or discriminative value. These elements should be taken into consideration in terms of individualization of septic patients' clinical status monitoring and treatment. The question why there is a strong correlation between PCT and WBC in patient groups with an extremely different septic response (survivors and septic shock subgroups) is open to further study.
